LSTM Health Economics, led by Professor Louis Niessen, has been developing steadily by setting up collaborations across the departments of LSTM and with selected key partner institutions in countries such as Bangladesh, Kenya, Malawi, Ghana and Cameroon.
These collaborations lead to funding opportunities, involvement in ongoing LSTM projects, and joint and stand-alone courses. The ongoing stream of related scientific publications focuses on the financial and equity impact of major diseases on households and health care systems and value-for-money options to combat those diseases in an efficient and equitable way.
The health economics activities involve a diversity of areas related to both infectious and chronic diseases, such as the major neglected tropical diseases, malaria, chronic diseases such as diabetes, cardiovascular disease, lung health, cancers.
Cross-cutting themes are catastrophic expenditures, poverty-impact of diseases, economic benefits of control programmes, the cost-effectiveness of new intervention programmes as well as their effects on access and impact inequalities.
Several high-impact studies on the chronic disease epidemics in low-income countries as well as related intervention studies have been published. In particular, there was the completion of a unique urban m-health diabetes intervention study in Dhaka and the completion of a 24-year follow-up study on chronic disease and household poverty in Matlab, both in Bangladesh. Also several studies were completed on the occurrence of malaria and household impact as well as the socio-economic impact of the control of neglected diseases.
The health economics group is strengthening the collaborations with the Universities of Warwick and Liverpool as well as with the identified partner institutions and universities across the globe.
LSTM Health Economics will contribute to LSTM’s mission to combat the impact of major diseases globally through the development of appropriate and affordable technologies in a demonstrated efficient and equitable way.